Published in Am J Obstet Gynecol on July 09, 2012
Field Trial of Maternal Influenza Immunization in Asia (Mothers'Gift) | NCT01034254
Optimizing benefits of influenza virus vaccination during pregnancy: potential behavioral risk factors and interventions. Vaccine (2014) 0.81
The National Vaccine Advisory Committee: reducing patient and provider barriers to maternal immunizations: approved by the National Vaccine Advisory Committee on June 11, 2014. Public Health Rep (2015) 0.79
Influenza vaccination in pregnant women: a systematic review. ISRN Prev Med (2013) 0.77
Influenza Vaccine Requirements in Pregnant Women. J Obstet Gynaecol India (2016) 0.75
Seasonal influenza vaccination in pregnant women: knowledge, attitudes, and behaviors in Italy. BMC Infect Dis (2017) 0.75
Immunologic response to vaccine challenge in pregnant PTPN22 R620W carriers and non-carriers. PLoS One (2017) 0.75
Efficacy and effectiveness of influenza vaccines: a systematic review and meta-analysis. Lancet Infect Dis (2011) 14.93
Prevention and control of influenza with vaccines: recommendations of the Advisory Committee on Immunization Practices (ACIP), 2010. MMWR Recomm Rep (2010) 10.59
Effectiveness and cost-benefit of influenza vaccination of healthy working adults: A randomized controlled trial. JAMA (2000) 8.31
Effectiveness of maternal influenza immunization in mothers and infants. N Engl J Med (2008) 7.79
Prevention of antigenically drifted influenza by inactivated and live attenuated vaccines. N Engl J Med (2006) 4.50
Effectiveness of influenza vaccine in health care professionals: a randomized trial. JAMA (1999) 3.71
Comparative efficacy of inactivated and live attenuated influenza vaccines. N Engl J Med (2009) 3.49
Pandemic influenza and pregnant women. Emerg Infect Dis (2008) 2.80
Emerging infections and pregnancy. Emerg Infect Dis (2006) 2.75
A randomized controlled trial of cold-adapted and inactivated vaccines for the prevention of influenza A disease. J Infect Dis (1994) 2.52
Safety of influenza vaccination during pregnancy. Am J Obstet Gynecol (2005) 2.47
Efficacy of repeated annual immunization with inactivated influenza virus vaccines over a five year period. Vaccine (1997) 1.95
2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol (2011) 1.69
Maternal immunization with influenza or tetanus toxoid vaccine for passive antibody protection in young infants. J Infect Dis (1993) 1.65
Prevention of symptomatic seasonal influenza in 2005-2006 by inactivated and live attenuated vaccines. J Infect Dis (2008) 1.58
Influenza immunization in pregnancy--antibody responses in mothers and infants. N Engl J Med (2010) 1.55
Pandemic influenza A H1N1 2009 infection versus vaccination: a cohort study comparing immune responses in pregnancy. PLoS One (2012) 1.55
Immunization of pregnant women with influenza A/New Jersey/76 virus vaccine: reactogenicity and immunogenicity in mother and infant. J Infect Dis (1979) 1.55
Effectiveness of influenza vaccine during pregnancy in preventing hospitalizations and outpatient visits for respiratory illness in pregnant women and their infants. Am J Perinatol (2004) 1.52
Effects of influenza on pregnant women and infants. Am J Obstet Gynecol (2012) 1.32
Immunogenicity of an inactivated monovalent 2009 H1N1 influenza vaccine in pregnant women. J Infect Dis (2011) 1.28
Antibody response to monovalent A/New Jersey/8/76 influenza vaccine in pregnant women. J Clin Microbiol (1979) 1.15
Efficacy of inactivated split-virus influenza vaccine against culture-confirmed influenza in healthy adults: a prospective, randomized, placebo-controlled trial. J Infect Dis (2009) 1.03
Influenza immunization: Statement. Public Health Rep (1960) 1.02
Maternal immune response and neonatal seroprotection from a single dose of a monovalent nonadjuvanted 2009 influenza A(H1N1) vaccine: a single-group trial. Ann Intern Med (2011) 1.00
EFFECTIVENESS OF POLYVALENT INFLUENZA VACCINE IN PREGNANCY. REPORT OF A CONTROLLED STUDY DURING AN OUTBREAK OF ASIAN INFLUENZA. Obstet Gynecol (1964) 0.88
Emergence of a novel swine-origin influenza A (H1N1) virus in humans. N Engl J Med (2009) 42.75
Antigenic and genetic characteristics of swine-origin 2009 A(H1N1) influenza viruses circulating in humans. Science (2009) 25.61
Influenza-associated hospitalizations in the United States. JAMA (2004) 18.23
Hospitalized patients with 2009 H1N1 influenza in the United States, April-June 2009. N Engl J Med (2009) 16.13
H1N1 2009 influenza virus infection during pregnancy in the USA. Lancet (2009) 12.32
The annual impact of seasonal influenza in the US: measuring disease burden and costs. Vaccine (2007) 9.96
Triple-reassortant swine influenza A (H1) in humans in the United States, 2005-2009. N Engl J Med (2009) 9.06
The underrecognized burden of influenza in young children. N Engl J Med (2006) 8.25
Pandemic 2009 influenza A(H1N1) virus illness among pregnant women in the United States. JAMA (2010) 5.94
Prevention and control of influenza: recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2004) 5.00
Decline in the prevalence of spina bifida and anencephaly by race/ethnicity: 1995-2002. Pediatrics (2005) 4.91
Maternal treatment with opioid analgesics and risk for birth defects. Am J Obstet Gynecol (2011) 4.14
Use of selective serotonin-reuptake inhibitors in pregnancy and the risk of birth defects. N Engl J Med (2007) 3.79
Prevention and control of influenza. Recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2005) 3.50
Fertility treatments and multiple births in the United States. N Engl J Med (2013) 3.45
Mortality associated with Down's syndrome in the USA from 1983 to 1997: a population-based study. Lancet (2002) 3.35
Methodologic issues regarding the use of three observational study designs to assess influenza vaccine effectiveness. Int J Epidemiol (2007) 3.33
The contribution of preterm birth to infant mortality rates in the United States. Pediatrics (2006) 3.01
Recent resurgence of mumps in the United States. N Engl J Med (2008) 2.90
A population-based study of the 22q11.2 deletion: phenotype, incidence, and contribution to major birth defects in the population. Pediatrics (2003) 2.88
Past, present, and possible future human infection with influenza virus A subtype H7. Emerg Infect Dis (2009) 2.80
Severe community-acquired pneumonia due to Staphylococcus aureus, 2003-04 influenza season. Emerg Infect Dis (2006) 2.79
Emerging infections and pregnancy. Emerg Infect Dis (2006) 2.75
Tubal factor infertility and perinatal risk after assisted reproductive technology. Obstet Gynecol (2013) 2.66
Influenza vaccination of health-care personnel: recommendations of the Healthcare Infection Control Practices Advisory Committee (HICPAC) and the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2006) 2.56
Birth outcomes following West Nile Virus infection of pregnant women in the United States: 2003-2004. Pediatrics (2006) 2.53
Prepregnancy obesity as a risk factor for structural birth defects. Arch Pediatr Adolesc Med (2007) 2.43
Maternal obesity and risk for birth defects. Pediatrics (2003) 2.33
Influenza- and RSV-associated hospitalizations among adults. Vaccine (2006) 2.23
Highly pathogenic avian influenza (H5N1): pathways of exposure at the animal-human interface, a systematic review. PLoS One (2011) 2.22
What obstetrician-gynecologists should know about Ebola: a perspective from the Centers for Disease Control and Prevention. Obstet Gynecol (2014) 2.04
Immunogenicity and reactogenicity of 1 versus 2 doses of trivalent inactivated influenza vaccine in vaccine-naive 5-8-year-old children. J Infect Dis (2006) 1.96
Influenza vaccination of recommended adult populations, U.S., 1989-2005. Vaccine (2008) 1.91
Trends and outcomes for donor oocyte cycles in the United States, 2000-2010. JAMA (2013) 1.90
Vaccination coverage among adults, excluding influenza vaccination - United States, 2013. MMWR Morb Mortal Wkly Rep (2015) 1.78
HIV seroprevalence among orphaned and homeless youth: no place like home. AIDS (2012) 1.76
Noninfluenza vaccination coverage among adults - United States, 2012. MMWR Morb Mortal Wkly Rep (2014) 1.74
Estimating influenza-associated deaths in the United States. Am J Public Health (2009) 1.73
Maternal nutrient intakes and risk of orofacial clefts. Epidemiology (2006) 1.70
2009 pandemic influenza A (H1N1) in pregnancy: a systematic review of the literature. Am J Obstet Gynecol (2011) 1.69
The burden of influenza in young children, 2004-2009. Pediatrics (2013) 1.68
Association between pregnancy intention and reproductive-health related behaviors before and after pregnancy recognition, National Birth Defects Prevention Study, 1997-2002. Matern Child Health J (2009) 1.68
Neurological and neuromuscular disease as a risk factor for respiratory failure in children hospitalized with influenza infection. JAMA (2005) 1.67
Maternal smoking and environmental tobacco smoke exposure and the risk of orofacial clefts. Epidemiology (2007) 1.67
Medications used to treat nausea and vomiting of pregnancy and the risk of selected birth defects. Birth Defects Res A Clin Mol Teratol (2011) 1.66
Assisted reproductive technology surveillance -- United States, 2010. MMWR Surveill Summ (2013) 1.64
Prescription medication borrowing and sharing among women of reproductive age. J Womens Health (Larchmt) (2008) 1.64
A population-based study of craniosynostosis in metropolitan Atlanta, 1989-2003. Am J Med Genet A (2008) 1.63
Seasonal influenza vaccines. Curr Top Microbiol Immunol (2009) 1.63
Are children born after assisted reproductive technology at increased risk for adverse health outcomes? Obstet Gynecol (2004) 1.61
Vaccine effectiveness against laboratory-confirmed influenza in children 6 to 59 months of age during the 2003-2004 and 2004-2005 influenza seasons. Pediatrics (2008) 1.56
Adverse event reports after tetanus toxoid, reduced diphtheria toxoid, and acellular pertussis vaccines in pregnant women. Am J Obstet Gynecol (2012) 1.56
Update: Interim Guidelines for Health Care Providers Caring for Pregnant Women and Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.56
Orofacial clefts in the National Birth Defects Prevention Study, 1997-2004. Am J Med Genet A (2009) 1.55
Incidence, complications, and risk factors for prolonged stay in children hospitalized with community-acquired influenza. Pediatrics (2007) 1.54
Impact of maternal immunization on influenza hospitalizations in infants. Am J Obstet Gynecol (2011) 1.52
Applying public health strategies to primary immunodeficiency diseases: a potential approach to genetic disorders. MMWR Recomm Rep (2004) 1.52
Surveillance of influenza vaccination coverage--United States, 2007-08 through 2011-12 influenza seasons. MMWR Surveill Summ (2013) 1.50
Disparities between black and white children in hospitalizations associated with acute respiratory illness and laboratory-confirmed influenza and respiratory syncytial virus in 3 US counties--2002-2009. Am J Epidemiol (2013) 1.50
States Monitoring Assisted Reproductive Technology (SMART) Collaborative: data collection, linkage, dissemination, and use. J Womens Health (Larchmt) (2013) 1.49
Assisted reproductive technology surveillance--United States, 2009. MMWR Surveill Summ (2012) 1.49
Health concerns of women and infants in times of natural disasters: lessons learned from Hurricane Katrina. Matern Child Health J (2007) 1.48
Estimating influenza hospitalizations among children. Emerg Infect Dis (2006) 1.41
Association between prepregnancy body mass index and congenital heart defects. Am J Obstet Gynecol (2009) 1.38
Maternal corticosteroid use and orofacial clefts. Am J Obstet Gynecol (2007) 1.34
Racial and ethnic disparities in influenza vaccination coverage among adults during the 2004-2005 season. Am J Epidemiol (2006) 1.33
U.S. physicians' perspective of adult vaccine delivery. Ann Intern Med (2014) 1.31
Interim Guidelines for the Evaluation and Testing of Infants with Possible Congenital Zika Virus Infection - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.29
Patterns of antidepressant medication use among pregnant women in a United States population. J Clin Pharmacol (2010) 1.28
The contribution of chromosomal abnormalities to congenital heart defects: a population-based study. Pediatr Cardiol (2011) 1.24
Update: Interim Guidance for Health Care Providers Caring for Women of Reproductive Age with Possible Zika Virus Exposure - United States, 2016. MMWR Morb Mortal Wkly Rep (2016) 1.21
Use of a human influenza challenge model to assess person-to-person transmission: proof-of-concept study. J Infect Dis (2011) 1.20
Maternal attitudes toward DNA collection for gene-environment studies: a qualitative research study. Am J Med Genet A (2009) 1.18
Priorities for future public health research in orofacial clefts. Cleft Palate Craniofac J (2007) 1.18
Seasonal influenza vaccination coverage among adult populations in the United States, 2005-2011. Am J Epidemiol (2013) 1.17
Reviewing the evidence for mycophenolate mofetil as a new teratogen: case report and review of the literature. Am J Med Genet A (2009) 1.17
Selective serotonin-reuptake inhibitors and persistent pulmonary hypertension of the newborn. N Engl J Med (2006) 1.16
Surveillance of Vaccination Coverage Among Adult Populations - United States, 2014. MMWR Surveill Summ (2016) 1.16
Assisted reproductive technology surveillance--United States, 2011. MMWR Surveill Summ (2014) 1.15
The status of public reporting of clinical outcomes in assisted reproductive technology. Fertil Steril (2013) 1.15
Correlates of seasonal influenza vaccine coverage among pregnant women in Georgia and Rhode Island. Obstet Gynecol (2010) 1.13
Maternal periconceptional alcohol consumption and risk of orofacial clefts. Am J Epidemiol (2007) 1.13
Prophylaxis and treatment of pregnant women for emerging infections and bioterrorism emergencies. Emerg Infect Dis (2006) 1.11
Lymphocytic choriomeningitis virus: an emerging obstetric pathogen? Am J Obstet Gynecol (2006) 1.11
Clinical features that discriminate inhalational anthrax from other acute respiratory illnesses. Clin Infect Dis (2003) 1.10
Medication use during pregnancy and lactation: an urgent call for public health action. J Womens Health (Larchmt) (2005) 1.10
Transmission of influenza A viruses between pigs and people, Iowa, 2002-2004. Influenza Other Respir Viruses (2010) 1.09
Using live, attenuated influenza vaccine for prevention and control of influenza: supplemental recommendations of the Advisory Committee on Immunization Practices (ACIP). MMWR Recomm Rep (2003) 1.08
Zika Virus Infection Among U.S. Pregnant Travelers - August 2015-February 2016. MMWR Morb Mortal Wkly Rep (2016) 1.08
Validity of parental report of influenza vaccination in young children seeking medical care. Vaccine (2011) 1.08
Influenza vaccination coverage among health care personnel--United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep (2014) 1.07
Advisory Committee on Immunization Practices (ACIP) recommended immunization schedule for adults aged 19 years and older--United States, 2013. MMWR Surveill Summ (2013) 1.06
Influenza vaccination coverage among pregnant women--United States, 2013-14 influenza season. MMWR Morb Mortal Wkly Rep (2014) 1.06
Monitoring seasonal influenza vaccination coverage among pregnant women in the United States. Am J Obstet Gynecol (2012) 1.05
Determinants of contraceptive choice among women with HIV. AIDS (2009) 1.04
Obstetrician/gynecologists' knowledge, attitudes, and practices regarding prevention of infections in pregnancy. J Womens Health (Larchmt) (2009) 1.03
Prevalence of self-reported infection during pregnancy among control mothers in the National Birth Defects Prevention Study. Birth Defects Res A Clin Mol Teratol (2009) 1.02
Population-based study of congenital diaphragmatic hernia: risk factors and survival in Metropolitan Atlanta, 1968-1999. Birth Defects Res A Clin Mol Teratol (2003) 1.02